KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Operating Leases (2018 - 2025)

Historic Operating Leases for Biogen (BIIB) over the last 8 years, with Q4 2025 value amounting to $370.8 million.

  • Biogen's Operating Leases fell 1190.31% to $370.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $370.8 million, marking a year-over-year decrease of 1190.31%. This contributed to the annual value of $370.8 million for FY2025, which is 1190.31% down from last year.
  • Per Biogen's latest filing, its Operating Leases stood at $370.8 million for Q4 2025, which was down 1190.31% from $305.0 million recorded in Q3 2025.
  • Biogen's 5-year Operating Leases high stood at $490.3 million for Q4 2023, and its period low was $274.2 million during Q2 2022.
  • In the last 5 years, Biogen's Operating Leases had a median value of $360.4 million in 2021 and averaged $364.8 million.
  • Its Operating Leases has fluctuated over the past 5 years, first tumbled by 2464.96% in 2022, then surged by 2431.19% in 2024.
  • Biogen's Operating Leases (Quarter) stood at $419.5 million in 2021, then increased by 2.55% to $430.2 million in 2022, then increased by 13.97% to $490.3 million in 2023, then dropped by 14.15% to $420.9 million in 2024, then dropped by 11.9% to $370.8 million in 2025.
  • Its last three reported values are $370.8 million in Q4 2025, $305.0 million for Q3 2025, and $310.9 million during Q2 2025.